A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians

Conducting Meta-Analyses in <i>R</i> with the <b>metafor</b> Package

Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · see citing works

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor–positive breast cancer: ATLAS, a randomised trial

Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044 · see citing works

Advanced methods in meta‐analysis: multivariate approach and meta‐regression

van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,574 · see citing works

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Hershman, D. L., Kushi, L. H., Shao, T. H., Buono, D. L., Kershenbaum, A., Tsai, W., Fehrenbacher, L., Gomez, S. L., Miles, S. Q., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 834 · see citing works

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708 · see citing works

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676 · see citing works

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

Partridge, A. H., LaFountain, A., Mayer, E. L., Taylor, B. S., Winer, E. P., & Asnis-Alibozek, A. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 483 · see citing works

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

Neugut, A. I., Subar, M., Wilde, E. T., Stratton, S., Brouse, C. H., Hillyer, G. C., Grann, V. R., & Hershman, D. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3179 · Cited by 354 · see citing works

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604758 · Cited by 343 · see citing works

Adherence to tamoxifen over the five-year course

Lash, T. L., Fox, M. P., Westrup, J., Fink, A. K., & Silliman, R. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9193-0 · Cited by 321 · see citing works

Analyzing survival curves at a fixed point in time

Klein, J. P., Logan, B. R., Harhoff, M., et al. (2007) · Statistics in Medicine · doi:10.1002/sim.2864 · Cited by 318 · see citing works

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F. J., Prout, M. N., Yood, M. U., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304 · see citing works

Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women

Demissie, S., Silliman, R. A., & Lash, T. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.322 · Cited by 301 · see citing works

Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast Cancer

Fink, A. K., Gurwitz, J. H., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.064 · Cited by 282 · see citing works

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

Ziller, V., Kalder, M., Albert, U., Holzhauer, W., Ziller, M., Wagner, U. A. G., & Hadji, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn646 · Cited by 263 · see citing works

Patient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use

Kahn, K. L., Schneider, E. C., Malin, J. L., Adams, J. L., & Epstein, A. M. (2007) · Medical Care · doi:10.1097/01.mlr.0000257193.10760.7f · Cited by 245 · see citing works

Adherence beliefs among breast cancer patients taking tamoxifen

Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2004.10.005 · Cited by 245 · see citing works

Adjuvant hormonal therapy use among insured, low-income women with breast cancer

Kimmick, G., Anderson, R., Camacho, F., Bhosle, M., Hwang, W., & Balkrishnan, R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2419 · Cited by 198 · see citing works

Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

Sedjo, R. L., & Devine, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0952-6 · Cited by 169 · see citing works

Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer

Dezentjé, V. O., van Blijderveen, N. J. C., Gelderblom, H., Putter, H., van Herk-Sukel, M. P. P., Casparie, M. K., Egberts, A. C. G., Nortier, J. W. R., & Guchelaar, H.-J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0894 · Cited by 163 · see citing works

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

van Herk‐Sukel, M. P. P., van de Poll-Franse, L. V., Voogd, A. C., Nieuwenhuijzen, G. A. P., Coebergh, J. W. W., & Herings, R. M. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0724-3 · Cited by 136 · see citing works

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study

Wigertz, A., Ahlgren, J., Holmqvist, M., Fornander, T., Adolfsson, J., Lindman, H., Bergkvist, L., & Lambe, M. P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1961-4 · Cited by 122 · see citing works

Meta-analysis of longitudinal studies

Ishak, K. J., Platt, R. W., Joseph, L., Hanley, J. A., & Jaime, J. (2007) · Clinical Trials · doi:10.1177/1740774507083567 · Cited by 120 · see citing works

Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients

Ma, A. M. T., Barone, J., Wallis, A. E., Wu, N. J., Garcia, L. B., Estabrook, A., Rosenbaum-Smith, S. M., & Tartter, P. I. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.06.027 · Cited by 115 · see citing works

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer

Nekhlyudov, L., Li, L., Ross‐Degnan, D., & Wagner, A. K. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1703-z · Cited by 99 · see citing works

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

Huiart, L., Bouhnik, A.-D., Rey, D., Tarpin, C., Cluze, C., Bendiane, M. K., Viens, P., & Giorgi, R. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.004 · Cited by 97 · see citing works

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

Thompson, A. M., Johnson, A., Quinlan, P., Hillman, G. R., Fontecha, M., Bray, S. E., Purdie, C. A., Jordan, L. B., Ferraldeschi, R., Latif, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1139-x · Cited by 87 · see citing works

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Rae, J. M., Sikora, M. J., Henry, N. L., Li, L., Kim, S., Oesterreich, S., Skaar, T. C., Nguyen, A., Desta, Z., Storniolo, A. M., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.14 · Cited by 86 · see citing works

Adherence to Adjuvant Hormonal Therapy and Its Relationship to Breast Cancer Recurrence and Survival Among Low-income Women

Weaver, K. E., CAMACHO, F. T., Hwang, W., Anderson, R. T., & Kimmick, G. G. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182436ec1 · Cited by 73 · see citing works

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer

Huiart, L., Dell’Aniello, S., & Suissa, S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.140 · Cited by 71 · see citing works

Endocrine Therapy Use Among Elderly Hormone Receptor-Positive Breast Cancer Patients Enrolled in Medicare Part D

Riley, G. F., Warren, J. L., Harlan, L. C., & Blackwell, S. A. (2011) · Medicare & Medicaid Research Review · doi:10.5600/mmrr.001.04.a04 · Cited by 58 · see citing works

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

Güth, U., Huang, D. J., Schötzau, A., Zanetti‐Dällenbach, R., Holzgreve, W., Bitzer, J., & Wight, E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604525 · Cited by 56 · see citing works

Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

Güth, U., Myrick, M. E., Schötzau, A., Kilic, N., & Schmid, S. M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1668-y · Cited by 49 · see citing works

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer

Schwartzberg, L. S., Cobb, P. W., Senecal, F. M., Henry, D. W., Kulig, K., Walker, M. S., Houts, A. C., & Stepanski, E. J. (2009) · The Breast · doi:10.1016/j.breast.2009.01.002 · Cited by 17 · see citing works

Compliance to adjuvant therapy in breast cancer patients.

Dittmer, C., Roeder, K., Hoellen, F., Salehin, D., Thill, M., & Fischer, D. (2011) · PubMed · Cited by 13 · see citing works

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study

McCowan, C., Wang, S., Thompson, A. M., Makubate, B., & Petrie, D. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.464 · Cited by 137 · see citing works

Behavioral interventions to enhance adherence to hormone therapy in breast cancer survivors: a systematic literature review

Hurtado-de-Mendoza, A., Cabling, M. L., Lobo, T., Dash, C., & Sheppard, V. B. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.03.006 · Cited by 79 · see citing works

Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: a systematic review and meta-analysis

Cahir, C., Guinan, E., Dombrowski, S. U., Sharp, L., & Bennett, K. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2015.05.013 · Cited by 84 · see citing works

The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer: Trajectories and Mortality

Winn, A. N., & Dusetzina, S. B. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4012 · Cited by 57 · see citing works

Strategies for the management of recurrent and advanced urologic cancers. Quality of life

Herr, H. W. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+ · Cited by 15 · see citing works

Feasibility and profile of patients of a randomized study comparing exclusive hormones therapy and hormones therapy associated to the radiotherapy in the treatment of the locally evolved prostate cancer

Richaud, P. M., Mottet, N. A., Peneau, M., et al. (2004) · Cancer/Radiothérapie

[Breast cancer and hormone therapy].

Izuo, M. (1987) · PubMed

Radiation Therapy Combined With Hormone Therapy for Prostate Cancer

LEE, A. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.003 · Cited by 23 · see citing works

[Adjuvant therapy of breast cancer. 2: Hormone therapy].

Possinger, K., Sauer, H., & Wilmanns, W. (1986) · PubMed